Skip to main content
FinSpry Logo
FinSpry
CRSP logo
CRSP
(NASDAQ)
CRISPR Therapeutics AG
$51.84-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

CRISPR Therapeutics (CRSP) Stock Price & Financial Analysis

CRISPR Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$52.29 - $59.00
52-Week High$78.48
52-Week Low$39.59
Open$52.42
Volume3.29M
Average Volume (3M)1.85M
Market Cap5.47B
Shares Outstanding96.05M
Price to Sales (P/S)1333.20
Price to Book (P/B)3.01
EV/EBITDA-11.16
Revenue (TTM)4.10M
Net Income (TTM)-568.53M
Free Cash Flow (TTM)-401.18M
EPS (TTM)$-6.24
Profit Margin-13856.54%
Operating Margin-13408.29%
Return on Equity (ROE)-31.33%
Debt to Equity0.32
50-Day MA$52.14
200-Day MA$55.61
52-Week Change34.41%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About CRISPR Therapeutics

What is the current stock price for CRSP?

As of the latest trading session, CRSP stock trades at $56.95. The 52-week range is $39.59–$78.48, with a day range of $52.29–$59.00.

What is the P/E ratio for CRSP?

The P/E ratio (Price-to-Earnings) for CRSP is shown in the Key Statistics section. This valuation metric helps compare CRISPR Therapeutics AG to industry peers.

Does CRSP pay dividends?

CRISPR Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CRSP?

Based on 1 analyst, the consensus for CRSP is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CRSP?

CRISPR Therapeutics's market capitalization is $5.47B, classifying it as a mid-cap company. CRISPR Therapeutics operates in the Healthcare sector within the Biotechnology industry.